Viridian Therapeutics, Inc. (VRDN): Free Cash Flow
-$276.89M
Year ended 2025-12-31
-$335.04M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$276.89M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$232.83M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$185.07M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$94.64M | n/m | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | -$54.92M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$29.82M | n/m | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | -$36.14M | n/m | 2021-03-26, From 2019-01-01 |
| 2018-12-31 | -$27.29M | n/m | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | -$28.41M | n/m | 2019-03-14, From 2017-01-01 |
| 2016-12-31 | -$15.01M | n/m | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | -$7.02M | n/m | 2017-03-24, From 2015-01-01 |
| 2014-12-31 | -$2.48M | n/m | 2016-03-21, From 2014-01-01 |
| 2013-12-31 | -$1.17M | n/a | 2015-03-27, From 2013-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | -$276.89M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$41.16M | n/m |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$1.20M | n/m |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$252.03M | n/m |
| Kura Oncology, Inc. (KURA) | 2025-12-31 | -$70.70M | n/m |
| AbCellera Biologics Inc. (ABCL) | 2025-12-31 | -$174.07M | n/m |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$75.81M | n/m |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | -$32.17M | n/m |
| Fortress Biotech, Inc. (FBIO) | 2024-12-31 | -$80.19M | n/m |
Compare VRDN, ASMB, RMTI, BCYC side by side · Screen every company in Pharmaceutical Preparations ↗